摘要
目的探讨荧光镜检技术（TruScreen）联合宫颈巴氏涂片筛查宫颈癌的诊断价值。方法将500例宫颈癌筛查者依次进行TruScreen联合宫颈巴氏涂片检查、宫颈巴氏涂片和阴道镜下宫颈活检，将病理结果与TruScreen联合宫颈巴氏涂片和宫颈巴氏涂片结果进行对照分析。结果TruScreen和巴氏涂片阳性分别为63例和49例，病理检查阳性为46例，TruScreen与巴氏涂片检测CIN的敏感度分别为95．65％和80．43％，特异度分别为62．75％和76．47％，差异有显著性（P〈0．05）。结论TruScreen联合宫颈巴氏涂片筛查宫颈癌具有准确率高的特点。
Objective To explore diagnostic value of the fluorescence microscopy technology combined with cervix pap smear in cervical cancer screening. Methods 500 women with cervical cancer screening were examined by TruScreen combined with pap smear screening, contraposed by the histology biopsy, and the difference of the two cytological examinations and the pathological examination were analyzed. Results The positive of TruScreen and cervix pap smear was 63 cases and 49 cases, the pathological examination was 46 cases, the sensitivity of CIN TruScreen and cervix pap smear were 95.65% and 80.43% respectively, and the specificity were 62.75% and 76.47% respectively,with statistical significant difference（P 〈 0.05）. Conclusion The fluorescence microscopy technology combined with cervix pap smear in cervical cancer screening has an advantage of high accuracy rate.
出处
《国际医药卫生导报》
2011年第24期3078-3081,共4页
International Medicine and Health Guidance News
关键词
宫颈癌
荧光镜检技术
宫颈巴氏涂片
Cervical cancer
Fluorescence microscopy technology
Cervix pap smear
